|
Inveni Capital offers entrepreneurial venture capital to life science companies in Northern and Central Europe.
Inveni Capital, established in 2007, is a life science focused venture capital firm. Inveni Capital invests in early to growth stage pharmaceutical development and medical technology companies in Northern and Central Europe.
Inveni Capital has offices in Helsinki, Finland and Munich, Germany.
Inveni Secondaries manages five life science dedicated venture capital funds. The management of these funds - originally Bio Fund Ventures funds - was transferred to Inveni Secondaries in summer 2010.
Inveni Secondaries actively manages the portfolio companies in these funds.
Inveni Secondaries has office in Helsinki, Finland.
|
